130 related articles for article (PubMed ID: 3744579)
21. Function of phagocytes in experimentally induced colitis in rabbits. II. The Shwartzman phenomenon in the colon.
Hermanowicz A; Hermel A; Nowak A; Sliwiński Z; Nawarska Z; Borys D; Banaś B
Int Arch Allergy Appl Immunol; 1986; 80(3):245-52. PubMed ID: 3721594
[TBL] [Abstract][Full Text] [Related]
22. Function of exudative neutrophilic granulocytes in patients with Crohn's disease or ulcerative colitis.
Wandall JH
Scand J Gastroenterol; 1985 Nov; 20(9):1151-6. PubMed ID: 4089525
[TBL] [Abstract][Full Text] [Related]
23. Psoriasis and leukocyte chemotaxis.
Tagami H; Iwatsuki K; Takematsu H
J Invest Dermatol; 1987 Mar; 88(3 Suppl):18s-23s. PubMed ID: 3493302
[TBL] [Abstract][Full Text] [Related]
24. Increased serum concentrations and surface expression on peripheral white blood cells of decay-accelerating factor (CD55) in patients with active ulcerative colitis.
Makidono C; Mizuno M; Nasu J; Hiraoka S; Okada H; Yamamoto K; Fujita T; Shiratori Y
J Lab Clin Med; 2004 Mar; 143(3):152-8. PubMed ID: 15007304
[TBL] [Abstract][Full Text] [Related]
25. Ontogeny of neutrophil chemotaxis in fetal lambs.
Raghunathan R; Faust J; Misra S; Miller ME
Pediatr Res; 1986 Mar; 20(3):265-8. PubMed ID: 3703615
[TBL] [Abstract][Full Text] [Related]
26. Generation of a neutrophil chemotactic agent by spermatozoa: role of complement and regulation by seminal plasma factors.
Clark RA; Klebanoff SJ
J Immunol; 1976 Oct; 117(4):1378-86. PubMed ID: 977954
[TBL] [Abstract][Full Text] [Related]
27. Defective serum chemotactic capacity in rheumatoid arthritis.
Attia WM; Ali MK; Abu-Ghazalah LM; Shams AH; Clark HW; Brown TM; Bellanti JA
Ann Allergy; 1983 Apr; 50(4):266-70. PubMed ID: 6838025
[TBL] [Abstract][Full Text] [Related]
28. IL-8 as an important chemoattractant for neutrophils in ulcerative colitis and Crohn's disease.
Mitsuyama K; Toyonaga A; Sasaki E; Watanabe K; Tateishi H; Nishiyama T; Saiki T; Ikeda H; Tsuruta O; Tanikawa K
Clin Exp Immunol; 1994 Jun; 96(3):432-6. PubMed ID: 8004812
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of neutrophil chemotaxis and chemokinesis associated with a plasma protein in aging rats: selective depression of cell responses mediated by complement-derived chemoattractants.
Mello SB; Farsky SH; Sannomiya P; Garcia-Leme J
J Leukoc Biol; 1992 Jan; 51(1):46-52. PubMed ID: 1311013
[TBL] [Abstract][Full Text] [Related]
30. Chemotactic responsiveness and random motility of polymorphonuclear leukocytes from patients with progressive systemic sclerosis.
Minta JO; Kovacs EK; Sukenik S; Lee P
J Rheumatol; 1985 Dec; 12(6):1125-8. PubMed ID: 4093918
[TBL] [Abstract][Full Text] [Related]
31. Chemotactic peptides modulate adherence of human polymorphonuclear leukocytes to monolayers of cultured endothelial cells.
Charo IF; Yuen C; Perez HD; Goldstein IM
J Immunol; 1986 May; 136(9):3412-9. PubMed ID: 3514759
[TBL] [Abstract][Full Text] [Related]
32. A neutrophil-immobilizing factor derived from human leukocytes. I. Generation and partial characterization.
Goetzl EJ; Austen KF
J Exp Med; 1972 Dec; 136(6):1564-80. PubMed ID: 4641855
[TBL] [Abstract][Full Text] [Related]
33. Mechanism for the inflammatory response in primate lungs. Demonstration and partial characterization of an alveolar macrophage-derived chemotactic factor with preferential activity for polymorphonuclear leukocytes.
Kazmierowski JA; Gallin JI; Reynolds HY
J Clin Invest; 1977 Feb; 59(2):273-81. PubMed ID: 401834
[TBL] [Abstract][Full Text] [Related]
34. Study of chemotactic activity developed by neutrophils from rheumatoid arthritis patients.
Bostan M; Constantin MC; Nicolau A; Hirt M; Galatiuc C; Matei I; Braşoveanu LI; Iordăchescu D
Roum Arch Microbiol Immunol; 2002; 61(4):243-58. PubMed ID: 15055258
[TBL] [Abstract][Full Text] [Related]
35. THE ROLE OF SERUM COMPLEMENT IN CHEMOTAXIS OF LEUKOCYTES IN VITRO.
WARD PA; COCHRANE CG; MUELLER-EBERHARD HJ
J Exp Med; 1965 Aug; 122(2):327-46. PubMed ID: 14316948
[TBL] [Abstract][Full Text] [Related]
36. Activation of the alternative complement pathway and generation of stimulating factors for granulocytes by glass fibers.
Governa M; Valentino M; Visona I; Marchiseppe I; Lo Martire N
Cell Biol Toxicol; 1988 Jun; 4(2):187-97. PubMed ID: 2852993
[TBL] [Abstract][Full Text] [Related]
37. Neutrophil chemotactic factor produced by lipopolysaccharide (LPS)-stimulated human blood mononuclear leukocytes: partial characterization and separation from interleukin 1 (IL 1).
Yoshimura T; Matsushima K; Oppenheim JJ; Leonard EJ
J Immunol; 1987 Aug; 139(3):788-93. PubMed ID: 3298433
[TBL] [Abstract][Full Text] [Related]
38. Defective T-lymphocyte chemotactic factor production in patients with established malignancy.
Cole D; Van Epps DE; Williams RC
Clin Immunol Immunopathol; 1986 Feb; 38(2):209-21. PubMed ID: 2934199
[TBL] [Abstract][Full Text] [Related]
39. Spontaneous aggregation of leukocytes in active ulcerative colitis might be ICAM-1 dependent.
Vainer B; Berliner S; Nielsen OH
Inflamm Res; 2004 Sep; 53(9):458-61. PubMed ID: 15550998
[TBL] [Abstract][Full Text] [Related]
40. Regulation of neutrophil migratory function in burn injury by complement activation products.
Solomkin JS; Nelson RD; Chenoweth DE; Solem LD; Simmons RL
Ann Surg; 1984 Dec; 200(6):742-6. PubMed ID: 6508405
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]